Technology | August 13, 2007

Hologic Introduces Biopsy Markers to Identify Multiple Biopsy Sites

Hologic Inc. recently introduced for the breast biopsy market in the U.S. two new second shape titanium breast biopsy markers, the TriMark 2S and CeleroMark 2S.
The TriMark 2S and CeleroMark 2S each contain a unique “hourglass” shape to help clinicians mark and independently identify multiple biopsy sites in the same breast.
The current Suros family of markers includes the ATEC TriMark and Suros CeleroMark biopsy site identifiers. These markers are compatible with the ATEC breast biopsy and excision system and Suros Celero ultrasound biopsy device, respectively. The standard TriMark identifier is a cylinder-shaped titanium pellet. The new 2S markers are half the size of the standard TriMark and can be used in conjunction with the current family of Suros biopsy site identifiers.

Related Content

Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Siemens Healthineers Introduces Mammomat Revelation Mammography System for Improved Biopsy Workflow
Technology | Mammography | December 11, 2017
Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society...
Hologic rings Nasdaq bell for breast cancer awareness
News | Breast Imaging | October 02, 2017
Hologic Inc. announced that Steve MacMillan, the company's chairman, president and CEO, joined selected employees to...
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
Top list of stories, article, videos for breast imaging.
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Sponsored Content | Videos | Women's Health | November 16, 2016
The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate...
stereotactic breast imaging

This image shows a 52-year-old patient with benign calcifications in her pre-stereotactic breast biopsy screening.

Feature | Breast Biopsy Systems | November 01, 2016 | By Laura Shepardson, M.D.
Recently, I was invited to participate in a...
Hologic, FDA approval, launch, Affirm prone biopsy system, breast cancer, women's health
Technology | Breast Biopsy Systems | April 21, 2016
Hologic Inc. announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm prone...
Overlay Init